Literature DB >> 4031509

The influence on the formation of unstable haemoglobin by the immunomodulating 2-cyanaziridines azimexone and BM 41.332 in mice.

B Isert, K Mengel, U Bicker, K D Friedberg.   

Abstract

Azimexone causes in mice the formation of unstable haemoglobins after a single dose of 20 mg/kg. BM 41.332, another immunomodulating drug of the 2-cyanaziridine class, induces these unstable haemoglobins only after a single oral administration of 500 mg/kg. Subsequently to the formation of unstable haemoglobins we observed a development of Heinz bodies. These effects of the 2-cyanaziridines were elicited neither by methaemoglobin formation nor by an impairment of the components protecting haemoglobin against oxidation (G6PD, catalase, glutathione). The elimination of the altered haemoglobin in the spleen could be followed by measurement of the rise in the iron content of the spleen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031509     DOI: 10.3109/08923978509047632

Source DB:  PubMed          Journal:  J Immunopharmacol        ISSN: 0163-0571


  2 in total

1.  Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolites.

Authors:  M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

2.  Ciamexone, a highly selective immunomodulator--a tool for autoimmune diseases?

Authors:  U Bicker; K H Usadel
Journal:  Klin Wochenschr       Date:  1986-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.